Skip to main content
. 2017 Mar 15;8(3):104–111. doi: 10.4239/wjd.v8.i3.104

Figure 2.

Figure 2

Mortality rates by age at death or final visit observed in the total group and treatment categories. PDE5I: Phosphodiesterase 5-inhibitors.